Antibiotics (Apr 2022)

Multicenter Study of Carbapenemase-Producing <i>Enterobacterales</i> in Havana, Cuba, 2016–2021

  • Haiyang Yu,
  • María Karla González Molina,
  • Yenisel Carmona Cartaya,
  • Marcia Hart Casares,
  • Meiji Soe Aung,
  • Nobumichi Kobayashi,
  • Dianelys Quiñones Pérez

DOI
https://doi.org/10.3390/antibiotics11040514
Journal volume & issue
Vol. 11, no. 4
p. 514

Abstract

Read online

Surveillance of carbapenem resistance is particularly important for Enterobacterales, mainly in countries with limited healthcare resources. We conducted a cross-sectional study to detect carbapenem-resistant Enterobacterales at 10 sentinel hospitals in Havana, Cuba for a six year-period (2016–2021) by the National Reference Laboratory for Health Care-Associated Infections in the Pedro Kourí Institute. A total of 152 isolates were collected with phenotypic production of metallo-β-lactamase. NDM-type carbapenemase was detected in all the 152 isolates, and KPC-type enzyme gene was simultaneously identified in four NDM-positive isolates. The most abundant carbapenemase-producing Enterobacterales (CPE) species was Klebsiella pneumoniae (69.7%), followed by Enterobacter cloacae complex (13.2%), and Escherichia coli (5.9%). Over the study period, among CPE, prevalence of K. pneumoniae was almost constant, while Enterobacter spp. showed slightly increasing tendency. The urinary tract (36.2%) was the most prevalent source of infection with CPE, followed by bloodstream (26.3%) and surgical wound (17.1%), being frequently derived from Intensive Care Units (35.5%) and urology wards (21.7%). This study revealed the present situation of CPE in hospitals in Havana, Cuba, showing the emergence and dissemination of Enterobacterales producing NDM-type carbapenemase, mainly K. pneumoniae.

Keywords